Prospects of intermittent preventive treatment of adults against malaria in areas of seasonal and unstable malaria transmission, and a possible role for chloroquine

Bibliography

• Malaria report 2009.Available from: http://www.who.int/malaria/world_malaria_report_2009/en/ index.html
   Google Scholar
• Creasey A, Giha H, Hamad AA, Eleven years of malaria surveillance in a Sudanese village highlights unexpected variation in individual disease susceptibility and outbreak severity. Parasitology 2004;129:263-71
   PubMed Web of Science ®Google Scholar
• World Health Organization, communicable diseases cluster: severe falciparum malaria. Trans R Soc Trop Med Hyg 2000;94:S1-90
   PubMedGoogle Scholar
• Giha HA, Elghazali G, A-Elgadir TM, Clinical pattern of severe Plasmodium falciparum malaria in Sudan in an area characterized by seasonal and unstable malaria transmission. Trans R Soc Trop Med Hyg 2005;99:243-51
   PubMedGoogle Scholar
• Al-Taiar A, Jaffar S, Assabri A, Severe malaria in children in Yemen: two site observational study. BMJ 2006;333(7573):827
   PubMedGoogle Scholar
• WHO guidelines for the treatment of malaria. World Health Organization, Geneva; 2006
   Google Scholar
• World Health Organization: the use of Artemisinin and its derivatives as anti- malarial drugsMalaria Unit, Division of Control of Tropical Disease, WHO, Geneva; 1998
   Google Scholar
• Denis MB, Tsuyuoka R, Poravuth Y, Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop Med Int Health 2006;11:1360-6
   PubMed Web of Science ®Google Scholar
• WHO: a strategic framework for malaria prevention and control during pregnancy in the African region Brazzaville: WHO Regional Office for Africa 2004
   Google Scholar
• Cissé B, Sokhna C, Boulanger D, Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 2006;367:659-67
   PubMed Web of Science ®Google Scholar
• Aponte JJ, Schellenberg D, Egan A, Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet 2009;374:1533-42
   PubMed Web of Science ®Google Scholar
• WHO Expert Committee on Malaria, Twentieth Report: technical report series 892. WHO, Geneva; 2000
   Google Scholar
• Geerligs PDP, Brabin BJ, Eggelete TA. analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Bull World Health Organ 2003;81:205-16
   PubMed Web of Science ®Google Scholar
• Schellenberg D, Menendez C, Aponte JJ, Intermittent preventive antimalarial treatment for Tanzanian infants; follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 2005;365:1481-3
   PubMed Web of Science ®Google Scholar
• Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol 2009;7:864-74
   PubMed Web of Science ®Google Scholar
• Fidock DA, Nomura T, Talley AK, Mutations in the P. falciparum digestive vacuole trans-membrane protein pfcrt- and evidence for their role in chloroquine resistance. Mol Cell 2000;6:861-71
   PubMed Web of Science ®Google Scholar
• Reed MB, Saliba KJ, Caruana SR, Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000;403:906-9
   PubMed Web of Science ®Google Scholar
• Berry A, Vessière A, Fabre R, Pfcrt K76T mutation and its associations in imported Plasmodium falciparum malaria cases. Infect Genet Evol 2004;4:361-4
   PubMedGoogle Scholar
• Giha HA, Elbashir MI, A-Elbasit IE, Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission. Acta Trop 2006;97:181-7
   PubMed Web of Science ®Google Scholar
• Ibrahim ML, Gay-Andrieu F, Adehossi E, Field-based evidence for the linkage of pfcrt and pfdhfr drug-resistant malaria genotypes and clinical profiles of severe malaria in Niger. Microbes Infect 2007;9:599-604
   PubMedGoogle Scholar
• Ranjit MR, Sahu U, Khatua CR, Chloroquine-resistant P. falciparum parasites and severe malaria in Orissa. Curr sci 2009;96:1608-11
   Google Scholar
• Osman ME, Mockenhaupt FP, Bienzle U, Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum. Infect Genet Evol 2007;7:52-9
   PubMedGoogle Scholar
• Giha HA, ElGhazali G, A-Elgadir TM, No evidence for implication of quinine treatment failure in development and fatality of cerebral malaria in Eastern Sudan. Int J Antimicrob Agents 2008;32:92-4
   PubMedGoogle Scholar
• Krause G, Schoneberg I, Altmann D, Stark K. Chemoprophylaxis and malaria death rates. Emerg Infect Dis 2006;3:447-51
   Google Scholar
• Elbasit IE, Alifrangis M, Khalil IF, The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics. Malar J 2007;6:108
   PubMedGoogle Scholar
• Djimdé AA, Doumbo OK, Traore O, Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg 2003;69:558-63
   PubMed Web of Science ®Google Scholar
• Rogerson S, Wijesinghe R, Meshnick S. Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria. Lancet Infect Dis 2010;10:51-9
   PubMed Web of Science ®Google Scholar
• Picot S, Nkwelle Akede A, Chaulet JF, Chloroquine self-treatment and clinical outcome of cerebral malaria in children. Clin Exp Immunol 1997;108:279-83
   PubMedGoogle Scholar
• Kublin JG, Cortese JF, Njunju EM, Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 2003;187:1870-5
   PubMed Web of Science ®Google Scholar
• Laufer MK, Thesing PC, Eddington ND, Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 2006;355:1959-66
   PubMed Web of Science ®Google Scholar
• Sisowath C, Petersen I, Veiga MI, In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. J Infect Dis 2009;199:750-7
   PubMed Web of Science ®Google Scholar
• Sisowath C, Strömberg J, Mårtensson A, In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis 2005;191:1014-17
   PubMed Web of Science ®Google Scholar
• Askjaer N, Maxwell C, Chambo W, Insecticide-treated bed nets reduce plasma antibody levels and limit the repertoire of antibodies to Plasmodium falciparum variant surface antigens. Clin Diagn Lab Immunol 2001;86:1289-91
   Google Scholar
• Kariuki SK, Lal AA, Terlouw DJ, Effects of permethrin-treated bed nets on immunity to malaria in western Kenya II. Antibody responses in young children in an area of intense malaria transmission. Am J Trop Med Hyg 2003;68:108-14
   PubMedGoogle Scholar
• Harrington WE, Mutabingwa TK, Muehlenbachs A, Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci USA 2009;106:9027-32
   PubMed Web of Science ®Google Scholar
• Giha HA, Elbashir MI, A-Elbasit IE, Bimodal transmission of cerebral malaria and severe malarial anemia and reciprocal co-existence of sexual and asexual parasitemia in an area of seasonal malaria transmission. Parasitol Res 2008;103:81-5
   PubMedGoogle Scholar
• Meerman L, Ord R, Bousema JT, Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. J Infect Dis 2005;192:1651-7
   PubMedGoogle Scholar